Drug Shortage Report for TEVA-TELMISARTAN HCTZ
| Report ID | 99952 |
| Drug Identification Number | 02330288 |
| Brand name | TEVA-TELMISARTAN HCTZ |
| Common or Proper name | TELMISARTAN/HCTZ 80/12.5MG TABS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE TELMISARTAN |
| Strength(s) | 12.5MG 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 & 100's |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-28 |
| Estimated end date | |
| Actual end date | 2022-01-05 |
| Shortage status | Resolved |
| Updated date | 2022-01-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.